BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:40:00 PM | Browse: 782 | Download: 594
Publication Name World Journal of Gastroenterology
Manuscript ID 4703
Country United States
Received
2013-07-17 10:24
Peer-Review Started
2013-07-17 15:09
To Make the First Decision
2013-09-09 16:54
Return for Revision
2013-09-15 18:58
Revised
2013-10-13 01:26
Second Decision
2013-11-04 17:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-11-05 10:08
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-11-20 09:22
Publish the Manuscript Online
2013-12-11 16:13
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care
Manuscript Source Invited Manuscript
All Author List Marija Zeremski, Jon E Zibbell, Anthony D Martinez, Steven Kritz, Bryce D Smith and Andrew H Talal
Funding Agency and Grant Number
Corresponding Author Andrew H Talal, MD, MPH, Professor, Chief, Division of Gastroenterology, Hepatology and Nutrition, State University of New York at Buffalo, UB/CTRC, 875 Ellicott Street, Suite 6090, Buffalo, NY 14203, United States. ahtalal@buffalo.edu
Key Words Treatment of hepatitis C; Viral infection; Human immunodeficiency virus; Hepatitis C virus coinfection; Persons who inject drugs; Obstacles to treatment
Core Tip Despite persons who inject drugs (PWIDs) representing the majority of the hepatitis C virus (HCV) disease burden, few receive treatment for HCV. Barriers to treatment uptake exist at multiple levels. Co-localization of HCV management with substance abuse facilities may result in greater treatment uptake for PWID.
Publish Date 2013-12-11 16:13
Citation Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World J Gastroenterol 2013; 19(44): 7846-7851
URL http://www.wjgnet.com/1007-9327/full/v19/i44/7846.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i44.7846
Full Article (PDF) WJG-19-7846.pdf
Manuscript File 4703-Review.docx
Answering Reviewers 4703-Answering reviewers.pdf
Copyright License Agreement 4703-Copyright assignment.pdf
Peer-review Report 4703-Peer review(s).pdf
Scientific Editor Work List 4703-Scientific editor work list.doc